Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Properly Label and Store Medications in Medication Carts

Peterborough, New Hampshire Survey Completed on 06-13-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that the facility failed to follow accepted professional principles for labeling and storing drugs and biologicals in two of three medication carts reviewed. Specifically, an open bottle of Brimodine eye drops was found without an open date, expiration date, or resident identifier. A box of Cipro ear drops labeled with an expiration date of 6/6 was stored in the medication cart alongside eye drops, contrary to facility policy requiring separation of medications by route of administration. Additionally, an open Breyna inhaler and an open Incruse Ellipta inhaler were found without open dates or open expiration dates. These findings were confirmed by interviews with LPNs responsible for the medication carts. Review of manufacturer instructions and facility policy indicated that these medications require labeling with open dates and must be discarded after specific periods post-opening. The facility's policy also mandates that eye and ear medications be stored separately and that outdated medications be immediately removed from stock. The observed deficiencies demonstrate non-compliance with both professional standards and facility policy regarding medication labeling and storage.

An unhandled error has occurred. Reload 🗙